COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
Late-breaking data from NOTUS confirm Dupixent's effectiveness in reducing COPD exacerbations and improving lung function, presented at ATS and published in NEJM -
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine & develop flu-COVID-19 combo vaccines. Agreement enhances patient access & protection. Details in press release
